-The Times of India NAGPUR: After voting rights if there has been any other weapon which has empowered an Indian citizen it is the Right to Information (RTI). RTI is used to seek information about matters which affect the aamadami. How much of information is being handed out is still a contentious issue, but the act has definitely created a battalion of social activists. An RTI activist is not exactly the harried...

-The Hindu     Protesters see attempt by EU to undermine Indian judiciary in the EU-FTA pact People living with HIV, cancer patient groups and pubLIC health activists came out on the streets on Wednesday demanding that India reject the European Union's demands in the European Union-India Free Trade Agreement (EU-India FTA) negotiations. The protests coincide with Prime Minister Manmohan Singh's visit to Germany to meet Chancellor Angela Merkel with the FTA on top of...

-The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, poLICies, court rulings of the country infringe upon...

-Frontline The Land Acquisition Bill runs into a roadblock as political parties fail to reach an agreement on the substantive features of the draft Bill or on the amendments proposed. The efforts of the United Progressive Alliance government to broker a consensus on the Right to Fair Compensation and Transparency in Land Acquisition, Rehabilitation and Resettlement Bill, 2012, which has been pending for over a year, have not paid off not because...

-The Times of India Big pharma may be crying hoarse over India's "weak'' intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country. That's not all. The contribution of patented drugs in the Rs 72,000-crore pharma retail market is not even 1%, indicating that multinationals have been traditionally slow and have a poor track record in introducing...